TGA moves to regulate autologous stem cells


A growing concern about the use of unproven autologous stem cell therapies to treat a wide range of conditions such as osteoarthritis has led the TGA to consider tightening its regulations. In a consultation paper published on Tuesday the TGA says concerns centre around the safety of the products, lack of evidence to support their ...


Already a member? Login to keep reading


OR
© 2017 the limbic